Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR‐TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomised patient preference trial evaluating long course concurrent chemoradiotherapy versus short course radiotherapy organ preservation approaches

Simon Bach , D Sebag‐montefiore , H Dewilt , Kl Garm‐spindler , Corrie Marijnen , Femke Peters , Peter Christensen , A Gilbert , Mark Teo , A Appelt , N West , V Homer , S Gates , N Christou , K Haustermans , A Wolthuis , A Debucquoy , A Martling , E Angenete , P Lind , R Keogh , L Navarro‐nuñez , Gunnar Baatrup , Issam Al‐najami , I Nagtegaal , Cl Andersen , I Tomlinson , A Beggs , R Fijneman , M Ligtenberg , James Hill , Nicola Fearnhead , Stephan Korsgen , Ian Geh , P Quirke , N Abbott , A Russell , C Forde , A Pallan , Ma Hawkins , Mg Guren , D Vimalchandran , M Lee , C Hurt , A Mirnezami , L Hiller , As Dhadda , S Magwaro , G Nixon , M Kaur , F Shi , I Nutt , C Smith , S Mee , K James , J Keely , Hans de Wilt , N Greijdanus , Audrey de Jong (1, 2) , L Smets , Heidi Rutten , James Good , Julian Hance , Alex Gilber , Fabian Holman , Laura Velema , Per Pfeiffer , Dibyendu Bandyopadhyay , Nathalie Casanova , Gl Beets , Mathew Tutton , Sadaf Usman , Karen‐lise Spindler , Jeroen Leijtens , Maaike Berbee , Sandeep Kapur , Debashis Biswas , Atanu Pal , James Wheeler , Rashmi Jardon , Noreem Alam , Mark Steward , Paul Hatfield , A ten Tije , Rhph Crolla , Gp van Der Schelling , Christopher Cunningham , Clare Jacobs , Stephen Boyce , Erik van Westreenen , Onne Reerink , Kathryn Mccarthy , Stephen Falk , Dareczka Wasowicz‐kemps , Robert Poorter , D Zimmerman , Michael Davies , Richard Adams , Apollo Pronk , Martijn Intven , Ian Sanders , Dorin Ziyaie , Jurriaan Tuynman , Debby Geijssen , Pim Burger , Jacqueline Theuws , Christiaan Hoff , Susanne Pereboom , Koen Talsma , Karin Muller , Ronald Vuylsteke , Michael Gerhards , Pascal Doornebosch , Joost Nuyttens

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]

Aim: Organ-saving treatment for early-stage rectal cancer can reduce patient-reported side effects compared to standard total mesorectal excision (TME) and preserve quality of life. An optimal strategy for achieving organ preservation and longer-term oncological outcomes are unknown; thus there is a need for high quality trials. Method: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC) is an international three-arm multicentre, partially randomized controlled trial incorporating an external pilot. In phase III, patients with cT1-3b N0 tumours, ≤40 mm in diameter, who prefer organ preservation are randomized 1:1 between mesorectal long-course chemoradiation versus mesorectal short-course radiotherapy, with selective transanal microsurgery. Patients preferring radical surgery receive TME. STAR-TREC aims to recruit 380 patients to organ preservation and 120 to TME surgery. The primary outcome is the rate of organ preservation at 30 months. Secondary clinician-reported outcomes include acute treatment-related toxicity, rate of non-operative management, non-regrowth pelvic tumour control at 36 months, non-regrowth disease-free survival at 36 months and overall survival at 60 months, and patient-reported toxicity, health-related quality of life at baseline, 12 and 24 months. Exploratory biomarker research uses circulating tumour DNA to predict response and relapse. Discussion: STAR-TREC will prospectively evaluate contrasting therapeutic strategies and implement new measures including a smaller mesorectal target volume, two-step response assessment and non-operative management for complete response. The trial will yield important information to guide routine management of patients with early-stage rectal cancer.

Mots clés: Chemoradiotherapy; Circulating free tumour DNA; Complete response; Early rectal cancer; Organ preservation; Short-course radiotherapy; Transanal endoscopic microsurgery; Watch and wait

Domaines: Sciences du Vivant [q-bio]

Simon Bach, D Sebag‐montefiore, H Dewilt, Kl Garm‐spindler, Corrie Marijnen, et al.. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR‐TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomised patient preference trial evaluating long course concurrent chemoradiotherapy versus short course radiotherapy organ preservation approaches. Colorectal Disease, 2022, 24 (5), pp.639-651. ⟨10.1111/codi.16056⟩. ⟨hal-03557736⟩